NEURODEM: assessment of the iatrogenic alert indicator for nursing home patients with Alzheimer's or Alzheimer-like disease

Aging Clin Exp Res. 2016 Oct;28(5):1015-21. doi: 10.1007/s40520-015-0502-5. Epub 2015 Dec 6.

Abstract

Introduction: Neuroleptics are known to induce Parkinsonism, tardive dyskinesia and their long-term use was associated with increased risk of hip fractures and impaired cognitive function and even death.

Methods: The primary objective of Neurodem study was to determine the IAI of patients with Alzheimer's disease in French NH.

Results: 1022 patients were enrolled. The IAI was 24.8 %. Multivariate logistic analysis showed that having a severe form of dementia, resident without MMS evaluation the last 12 months and having a prescription for an anxiolytic drug were associated with a higher risk of having a prescription for an antipsychotic drug.

Conclusion: The results from our study show that the percentage of patients receiving an antipsychotic drug (24.8 %) was higher than the national average (18 %). Effective educational activities about appropriate use of antipsychotic drugs in patients with Alzheimer's disease are needed.

Keywords: Alzheimer’s disease; Neuroleptic drug prescription; Neuropsychiatric symptoms; Nursing home.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / drug therapy*
  • Antipsychotic Agents / adverse effects*
  • Dementia / drug therapy
  • Female
  • Humans
  • Iatrogenic Disease
  • Male
  • Nursing Homes*

Substances

  • Antipsychotic Agents